Co-Diagnostics, Inc. (CODX) community

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Community

Notes and questions about Co-Diagnostics from other investors

No posts about CODX yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Co-Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jan 2, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CODX.

Compare: CODX vs SINT · CODX vs INBS · CODX vs PETV · CODX vs FEMY · CODX vs HRGN

Revenue growth69.1% · median 36.5%

Gross margin20.3% · median 59.5%

Operating margin-5614.3% · median -683.3%

Net margin-5527.6% · median -511.8%

Company	Revenue	Growth
INBS	$4.50M	+36.5%
SINT	$3.31M	+160.8%
FEMY	$2.30M	+21.9%
PETV	$1.18M	-9.5%
HRGN	$982.00K	+44.6%
CODX	$858.89K	+69.1%

Company

Next earnings (est.): Mar 30, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 115
Held by institutions: 9.5%
Auditor: Tanner LLP
SEC CIK: 1692415

Advertisement
300 × 250

See a number that looks wrong?